Cancer Research

Genomic data provided through expanded testing allowed 14.5 percent of patients to transition to safer treatment options, significantly reducing the risks of therapy-related complications and morbidity. This breakthrough underscores a fundamental shift in the oncological landscape, where the focus

Before undergoing advanced cell therapy, Martha Durden-Scroggins experienced extreme physical fluctuations, oscillating between periods of stability and bouts of debilitating weakness. At seventy-one, her aggressive B-cell lymphoma had reached a critical juncture where conventional interventions no

While traditional CAR-T therapies often focus on a single antigen, C-CAR039 utilizes a dual-targeting mechanism to reduce the likelihood of tumor escape in aggressive lymphoma cases. This specific design addresses one of the most significant challenges in cellular immunotherapy: the down-regulation

A woman’s geographic location within Sweden’s borders might currently play a more decisive role in her cancer recovery than the genetic mutations found within her tumor cells. Despite a reputation for providing world-class, egalitarian medical care, the Swedish healthcare system is grappling with

Advances in protein design and enzyme engineering now allow for the rapid modification of bioactive substances, such as decaffeinating beverages in minutes by mimicking the body’s natural metabolic pathways. This breakthrough represents a broader shift toward what Aryeh Ganz and Cornucopian Capital

Detecting minimal residual disease through high-sensitivity blood tests allows clinicians to identify high-risk patients who might benefit from immediate cellular therapy despite appearing to be in remission. This shift toward early intervention represents a departure from traditional